SCCT2026 brings together clinicians and researchers from around the world to advance the science and practice of ...
As heart disease strikes Indians younger and harder than ever before, Chennai-based interventional cardiologist Dr. Babu Ezhumalai is urging a rethink of one of the country's most trusted cardiac ...
Medical University of Graz has enrolled the first patient in the DEEPER CHALLENGE clinical trial. This investigator-initiated, single-center, single-arm, prospective study, supported by a grant, ...
Endologix LLC, a privately held, global medical device company focused on advancing innovative therapies for the interventional treatment of vascular disease, today announced publication of 36-month ...
Morning Overview on MSN
A gut-heart link may explain why sleep apnea quietly raises heart-disease risk
People with obstructive sleep apnea face elevated rates of coronary heart disease and cardiovascular death, yet treating the ...
A new study has found that people with stronger, better quality back and chest muscles may be at a reduced risk of a heart ...
Elucid to Showcase CCTA Vision at SCCT 2026, Defining the Future of Personalized Cardiovascular Care
Elucid, an innovator in AI-powered coronary CT angiography (CCTA) analysis, today announced its largest and most ...
Chennai: Tamil Nadu’s state-run network for treating STEMI — the most severe form of heart attack, caused by a complete ...
The Medical University of Graz has enrolled the first patient to evaluate Reflow Medical’s Spur Peripheral Retrievable Scaffold System in the DEEPER CHALLENGE study. The single- ...
For patients who receive heart-sparing radiotherapy for breast cancer, coronary artery dose is key in the risk for future cardiac events.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results